Eric Adams

Currently holds a position at InMed Pharmaceuticals Inc

1.6

1.6

Position	Company	Period
President, Chief Executive Officer, Director	InMed Pharmaceuticals Inc	June 16, 2016 -

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2024-02-21	2024-02-20	InMed Pharmaceuticals Inc (INM)	B Purchase	96,316 +27.2% 399.46 US$4,453,937	96,316 +27.2%	399.46	US$4,453,937
2022-04-18	2022-04-14	InMed Pharmaceuticals Inc (INM)	B Purchase	2,935 +3.1% 56.46 US$3,748,721	2,935 +3.1%	56.46	US$3,748,721
2022-04-13	2022-04-13	InMed Pharmaceuticals Inc (INM)	B Purchase	39,425 -5.5% 376.86 US$2,004,122	39,425 -5.5%	376.86	US$2,004,122
2021-09-29	2021-09-28	InMed Pharmaceuticals Inc (INM)	B Purchase	11,400 +70.9% 1.75 US$19,984	11,400 +70.9%	1.75	US$19,984